Lifeloc Technologies, Inc. filings document a Colorado operating company that reports as an SEC registrant and trades common stock under LCTC. Its Form 8-K reports furnish operating results, Regulation FD releases, and material-event disclosures tied to the company’s breath alcohol and drug detection device business.
The filing record also covers material financing agreements, debt terms, security interests, capital-structure matters, and the use of proceeds for continued SpinDetect™ product development. Proxy materials describe annual shareholder voting matters, director elections, auditor ratification, governance procedures, and common-stock ownership information.
Lifeloc Technologies, Inc. filed a current report to note that on September 23, 2025 it issued a press release titled “Lifeloc to Present at Emerging Growth Conference on September 25, 2025.” The company is using this filing to formally furnish that press release to the market and to clarify that the release, and any websites linked within it, are not considered “filed” for liability purposes under the Securities Exchange Act or automatically incorporated into other securities filings.
Lifeloc Technologies, Inc. filed a current report to note that on September 23, 2025 it issued a press release titled “Lifeloc to Present at Emerging Growth Conference on September 25, 2025.” The company is using this filing to formally furnish that press release to the market and to clarify that the release, and any websites linked within it, are not considered “filed” for liability purposes under the Securities Exchange Act or automatically incorporated into other securities filings.